Different Doses of ZED1227 vs. Placebo in NAFLD

Clinical trial NCT05305599 · COMPLETED

Trial details

NCT number: NCT05305599
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NAFLD Liver Fibrosis

Start date: 2022-04-19
Primary completion: 2023-06-07
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.